ALNYLAM PHARMACEUTICALS, INC. (20) | Uncategorized (6)

Recent Contracts

Co-Development Agreement between the Registrant and BXLS (Filed With SEC on November 5, 2020)
First Amendment to (Filed With SEC on November 5, 2020)
Letter Agreement between the Registrant and Barry E. Greene dated August 26, 2020 (Filed With SEC on November 5, 2020)
Patent Cross-License Agreement dated April 3, 2020 between Dicerna Pharmaceuticals, Inc. and the Registrant (Filed With SEC on August 6, 2020)
Investor Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
Amended and Restated Investor Agreement dated as of April 8, 2019 by and between the Registrant and Genzyme Corporation (Filed With SEC on August 6, 2019)